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microRNAs (miRNAs) bind to specific messen-
ger RNA targets to posttranscriptionally modu-
late their expression. Understanding the regula-
tory relationships between miRNAs and targets
remains a major challenge. Many miRNAs re-
duce expression of their targets to inconse-
quential levels. It has also been proposed that
miRNAs might adjust target expression to an
optimal level. Here we analyze the conse-
quences of mutating the conserved miRNA
miR-8 in Drosophila. We identify atrophin as
a direct target of miR-8. miR-8 mutant pheno-
types are attributable to elevated atrophin
activity, resulting in elevated apoptosis in the
brain and in behavioral defects. Reduction of
atrophin levels in miR-8-expressing cells to
below the level generated by miR-8 regulation
is detrimental, providing evidence for a ‘‘tuning
target’’ relationship between them. Drosophila
atrophin is related to the atrophin family of
mammalian transcriptional regulators, impli-
cated in the neurodegenerative disorder DRPLA.
The regulatory relationship between miR-8 and
atrophin orthologs is conserved in mammals.
INTRODUCTION
microRNAs (miRNAs) are short noncoding RNAs that
serve as posttranscriptional regulators of gene expression
in plants and animals (reviewed in Kloosterman and Plas-
terk, 2006; Mallory and Vaucheret, 2006; Bushati and
Cohen, 2007). The roles of miRNAs in animal development
have been the subject of considerable interest. Hundreds
of miRNAs have been identified, and computational
methods have predicted hundreds of targets for the aver-
age miRNA, leading to proposals that one-third or more of136 Cell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc.the transcriptome may be miRNA regulated (e.g., Bren-
necke et al., 2005; Grun et al., 2005; Lewis et al., 2005;
Stark et al., 2005).
Recent studies comparing miRNA and target expres-
sion have suggested that many miRNAs serve to limit
target gene expression in tissues, where target expression
is normally low and where leaky expression would be
detrimental (Farh et al., 2005; Stark et al., 2005). Acting
in this mode, miRNAs can be thought of as having
a switch-like function to eliminate target expression (Bar-
tel and Chen, 2004). The idea of mutual exclusion can also
operate temporally. An elegant example of this is the role
of miR-430, the first miRNA expressed in the zebrafish
embryo, in promoting turnover of maternally encoded
mRNAs (Giraldez et al., 2005). These studies have led to
the proposal that the main role of many miRNAs is to
exclude target RNA expression to ensure robustness of
developmental processes (Stark et al., 2005; Hornstein
and Shomron, 2006). A recent study of the miR-9b miRNA
mutant has shown a phenotype best described as a failure
in robustness (Li et al., 2006). miR-9b sets a threshold for
activation of a positive feedback loop involved in cell-fate
specification in sensory nervous system of Drosophila by
regulating the proneural transcription factor senseless
(Nolo et al., 2000). Failure to limit senseless expression
leads to a sporadic activation and to variability in the num-
ber of sensory organs produced.
Another possible mode of miRNA function involves
‘‘tuning’’ the expression level of target RNAs with which
they are normally coexpressed (Bartel and Chen, 2004).
Although this model is appealing, it has received little
experimental support to date from study of miRNA func-
tions in vivo. Here, we analyze the functions of miR-8 in
Drosophila and identify the transcriptional regulator atro-
phin as a direct functional target of this miRNA. Atrophin
is broadly expressed during development, and defects
associated withmiR-8mutants are attributable to a failure
to limit atrophin expression in miR-8-expressing cells, re-
sulting in elevated apoptosis in the brain and behavioral
defects. We provide evidence that miR-8 tunes the level
of atrophin expression, because further reduction of
Figure 1. MiR-8 Mutants
(A) Schematic representation of the miR-8
locus. miR-8 is located on chromosome 2R at
53D11 on the cytological map. Lower panel:
breakpoints of three miR-8 mutant alleles and
the insertion sites of the P elements used to
generate these alleles. The insertion site of
the Gal4 containing P element (miR-8Gal4) is
indicated. miR-8D3 was generated by male
recombination using the P element EP2239.
The deletion spans 26 kb, and the breakpoint
was determined by DNA sequencing. miR-8D2 was produced via imprecise excision by mobilization of P element EP2269, and the deletion spans
1.8 kb. miR-8D1 was produced by targeted knockout. Four hundred base pairs spanning the miR-8 locus was replaced by the miniwhite gene.
(B) Northern blot showing miR-8 RNA in a wild-type control andmiR-8mutant allelic combinations. D2a and D2b are independent homozygous lines
of miR-8D2.atrophin levels in miR-8-expressing cells is detrimental.
Regulation of atrophin by miR-8 constitutes a biologically
significant example of tuning target mRNA expression in
the nervous system. Further, this study implicates miR-8
in development and function of the nervous system and
suggests a possible connection to neurodegenerative
disease.
RESULTS
miR-8 Mutants
To analyze the function of miR-8 in Drosophila we gener-
ated loss of function mutant alleles (Figure 1A). mir-8D1
was produced by homologous recombination. A 400 bp
fragment, spanning the miR-8 hairpin, was replaced by
the miniwhite gene. miR-8D2 andmiR-8D3 were produced
by imprecise excision of the P elements P(EP)2269 and
P(EP)2239. The deletions removed 1.8 kb and 26 kb,
respectively. Northern blot analysis confirmed that the
mature miR-8 product was not produced in any of the
three alleles (Figure 1B).
The phenotypes resulting from removal of miR-8 were
analyzed in the three possible allelic combinations to ex-
clude potential effects of genetic background. Although
miR-8 is expressed in a complex pattern in the embryo
and in larvae (Figure S1), mutants lacking miR-8 com-
pleted larval development normally but showed reduced
survival during pupal and early adult stages (Figure 2A).
Of the 14%–19% of mutants that died, 80% failed to
emerge from the pupal case and the remainder died within
the first 24 hr of adult life. Most of this latter group had
malformed third legs. Thirty-three to fifty percent of the
surviving adults showed a similar leg defect (Figures 2C
and 2E). Twenty-two to thirty-two percent of the surviving
adults had wings that were not properly unfolded (Figures
2B and 2D). In this analysis, mutant animals were sepa-
rated from their heterozygous siblings to minimize the
effects of competition with healthier animals during larval
stages. Survival of the mutants was reduced further
when they were reared together with their siblings (e.g.,
Figure 5B).
To examine the basis for these morphological defects,
we performed a genetic mosaic analysis. Clones ofmiR-8
mutant cells produced in the leg and wing imaginal discsdid not cause morphological defects in adult wings or
legs. This suggests that the observed defects were not
due to a requirement for miR-8 activity in the imaginal
disc epithelia per se, although miR-8 is expressed there
(Figures S1F and S1G). Although malformed, miR-8 mu-
tant legs and wings were patterned normally. Such de-
fects might result from improper unfolding of the imaginal
discs during emergence of the adult fly from the pupal
case. Time-lapse imaging showed that wild-type flies
freed themselves from the pupal case very rapidly. miR-8
mutants, in contrast, appeared to have difficulty detach-
ing themselves, with a leg or wing often becoming en-
tangled (Movie S1). Manymutants died after several hours
of struggle. Mechanical damage to legs and wings can
occur in those that manage to pull free, particularly if
they fail to do so before the adult cuticle hardens. The
leg abnormalities may also reflect an earlier defect. Leg
and wing imaginal disc morphogenesis involves eversion
of the disc epithelium and elongation during pupal stages
(see Fristrom and Fristrom, 1993). miR-8 mutants often
failed to extend their legs properly within the pupal case
and showed mild malformations (Figure S2). It has been
suggested that pressure generated by contraction of the
abdominal muscles is a major driving force for leg and
wing extension at the prepupal-pupal transition (Fortier
et al., 2003). Impaired neuromuscular coordination could
cause the defects we observed in miR-8 mutant legs.
MiR-8 Regulates Atrophin
miRNAs are predicted to have many targets (Brennecke
et al., 2005; Lewis et al., 2005; Grun et al., 2005; Xie
et al., 2005; Krek et al., 2005). Drosophila miR-8 has
over 250 conserved predicted targets (Stark et al., 2005;
Grun et al., 2005). In view of its complex spatial and tem-
poral expression pattern (Figure S1), miR-8 might be
expected to regulate different target RNAs in different
contexts. Misregulation of only a small subset of these
might be responsible for the observed mutant pheno-
types. Previous reports have shown that target RNA levels
can be altered either by overexpressing miRNAs in cells
where they are not normally expressed (Lim et al., 2005;
Behm-Ansmant et al., 2006), by eliminating miRNA pro-
duction globally (Giraldez et al., 2006; Rehwinkel et al.,
2006) or using mutants that remove specific miRNAsCell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc. 137
Figure 2. MiR-8 Mutant Phenotypes
(A–C) Histograms illustrating the severity of the defects in the three different miR-8 mutant combinations. Animals were grown under controlled
conditions. The data represent an average ± standard deviation (SD) of 8 batches of 100 flies for each genotype. (A) shows the reduced survival
of adult flies. Approximately 80% of the dead individuals failed to eclose from the pupal case. The remainder died within the first 24 hr after eclosion.
Most of these animals had a malformed third leg. (B) shows the percentage of surviving adults with wing defects. Wings ofmiR-8mutants often failed
to unfold normally (see D). (C) shows the percentage of surviving adults with leg defects. The third leg pairs of miR-8 mutant animals were often
severely malformed (see E). (D) and (E) show cuticle preparations of control and miR-8 mutant wings and legs.(Teleman et al., 2006). In this context, we looked for genes
predicted to be miR-8 targets that were upregulated in
miR-8mutants. Expression profiling was performed using
two combinations of miR-8 mutant alleles. RNA was pre-
pared from pupae, as the mir-8 mutant phenotypes were
apparent during late pupal stages. Approximately 200
genes were reproducibly upregulated by at least 2-fold
inmiR-8mutants (Table S1). This group is expected to in-
clude direct miR-8 targets and genes affected indirectly.
The latter group likely predominates, as a similar number
of RNAs were downregulated. Among the upregulated
genes, only four had miR-8 target sites that were con-
served between D. melanogaster and D. pseudoobscura:
CG13060, CG8420, CG9036, and CG6964 (Drosophila
atrophin).
miRNA target sites are most often found in 30UTRs. The
atrophin 30UTR has four potential miR-8 target sites, two
of which are conserved in D. pseudoobscura (Figure 3A).
Interestingly, this regulatory relationship appears to be
conserved in mammals. Two human miRNAs, miR-200b
and miR-429, are identical to miR-8 in the seed region
(residues 2–8), the major determinant of miRNA target
specificity (Brennecke et al., 2005; Lewis et al., 2005).
Three potential target sites for miR-200b and miR-429
were found in the 30UTR of the human othologue of atro-
phin, RERE (Figure 3B).
On the basis of the apparent conservation of this regu-
latory relationship, we focused our analysis on atrophin as
a possiblemiR-8 target. We first verified themicroarray re-
sults by quantitative real-time RT-PCR. atrophin mRNA
levels were 2-fold higher in homozygousmiR-8mutants
at early pupal stages (Figure 4A). In view of the change in
atrophin mRNA level, it was of interest to determine
whether the effect of miR-8 was directly posttranscrip-
tional or indirect, reflecting a change in transcription. To
address this, we performed real-time RT-PCR comparing
the level of the nuclear atrophin primary transcript with
that of the mature mRNA. miRNA-mediated gene regula-
tion takes place in the cytoplasm and so should not affect138 Cell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc.the primary transcript in the nucleus. Real-time RT-PCR
using intron-specific primers provides a means to com-
pare atrophin primary transcript levels with the levels of
the mature mRNA in the cytoplasm, using primers located
in the exons. If upregulation of atrophinmRNA was due to
increased transcription, we would expect primary tran-
script levels to increase in miR-8 mutants. However, this
proved not to be the case. Only the mature mRNA level in-
creased (Figure 4A). Thus, the increase in atrophin mRNA
in themiR-8mutant is posttranscriptional, suggesting that
miR-8 binding leads to destabilization of atrophin mRNA.
Can the effect on atrophin mRNA stability be attributed
to the miR-8 sites in its 30UTR? To address this, we gener-
ated transgenic flies expressing a luciferase reporter gene
linked to the atrophin 30UTR or a version of this UTR in
which the miR-8 sites were mutated. Q-PCR analysis
showed that the level of luciferase mRNA increased
in the miR-8 mutants for the construct with the intact
miR-8 sites, but not when these sites were mutated
(Figure 4B). Coexpression of the luciferase reporters in
S2 cells with miR-8 reduced luciferase mRNA levels to
60% (Figure 4C). A comparable reduction of luciferase
enzyme activity was observed in response to miR-8
(Figure 4D), and this effect was largely eliminated when
the miR-8 sites were mutated (Figure 4D). Together these
observations provide evidence that miR-8 acts directly via
these sites to control atrophin expression in vivo. miR-429
and miR-200b were also able to regulate a luciferase re-
porter containing the human RERE 30UTR (Figures 4E
and 4F), suggesting conservation of this relationship.
Atrophin Overexpression Contributes to themiR-8
Mutant Phenotype
To askwhether atrophin protein levels were elevated in the
miR-8 mutants, we performed immunoblots on lysates
from control flies and two miR-8 mutant combinations.
As a positive control for antibody specificity we used flies
overexpressing the endogenous atrophin gene from an
EP element insertion under Gal4 control. Lysates were
Figure 3. MiR-8 Target Sites Are Conserved
(A) Four potential miR-8 target sites in the atrophin 30UTR. The sites depicted in red are conserved in Drosophila pseudobscura.
(B) Three potential target sites of miR-429, the 30UTR of RERE. All are conserved in mouse.prepared from brain, body wall (muscle and epidermis),
and gut from wandering third instar larvae. Atrophin pro-
tein levels were detectably higher in miR-8 mutant brain
(Figure 5A) and in body wall but not in gut tissue (not
shown). Two protein forms at 280 kDa and a shorter
150 kDa protein were expressed more strongly in the
miR-8 mutants than in the control animals. Although the
predicted Mr of atrophin is 260 kDa (Erkner et al.,
2002), both of the 280 kDa protein forms and the 150
kDa protein were induced by Gal4-directed overexpres-
sion of the endogenous atrophin gene, confirming that
they are authentic products of this locus.
If atrophin mRNA is a functionally important miR-8 tar-
get in vivo, we would expect that overexpression of atro-
phin protein contributes to the miR-8 mutant phenotype.
We therefore asked whether removing one copy of theatrophin gene would reduce the severity of themiR-8mu-
tant phenotype. Reducing atrophin activity rescued the
survival defect of the mir-8 mutant by 50% (Figure 5B).
The increase in survival was statistically significant (t
test: 9.1 3 107). The proportion of surviving adults that
showed a leg defect was reduced by 40% (t test: 1.8 3
104), and the leg malformations were less severe than
in miR-8 mutants with full atrophin activity. These obser-
vations suggest that misregulation of atrophin contributes
to the defects observed in the miR-8 mutant. To ask
whether overproduction of atrophin is sufficient to cause
these defects, we made use of a Gal4 P element insertion
at the miR-8 gene to direct overexpression of the endog-
enous atrophin gene inmiR-8-expressing cells. These an-
imals showed a similar spectrum of defects to the miR-8
mutants. Survival was reduced, and the surviving animalsFigure 4. Posttranscriptional Regulation of atrophin RNA by MiR-8
(A) Real-time RT-PCR on atrophin using intron-specific primers (left) and exon-specific primers (right) in control andmiR-8mutant animals (7 hr after
puparium formation).
(B) Real-time RT-PCR on luciferase reporter transgenes containing either the normalDrosophila atrophin 30UTR (left) or one where all fourmiR-8-bind-
ing sites were mutated in the seed sequence. Two or three nucleotides were exchanged per seed, such that consecutive binding betweenmiR-8 and
the atrophin 30UTR was interrupted at these positions. Transgenes were expressed under control of the tubulin promoter in control w1118 andmiR-8
mutant flies.
(C) Q-PCR on luciferase reporter transgenes containing either the normal Drosophila atrophin 30UTR (left) or, as a control, the SV40 30UTR (right). The
30UTR luciferase reporter plasmids were coexpressed with miR-8 or a control.
(D) Normalized luciferase activity for a reporter transgene containing the atrophin 30UTR and onewhere all fourmiR-8-binding sites weremutated. The
30UTR was coexpressed with miR-8 or with a vector-only control.
(E) Normalized luciferase activity for a reporter transgene containing the 30UTR of RERE, the human atrophin ortholog, and a control 30UTR. The 30UTR
was either coexpressed with miR-429, one of the human miR-8 orthologs, or a control.
(F) As (E), except for cotransfection with miR-200b. The data represents average ± SD for all panels.Cell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc. 139
Figure 5. Atrophin Protein Levels Are Misregulated in miR-8 Mutants and Contribute to Its Phenotypes
(A) Immunoblot showing atrophin protein levels in lysates prepared from third instar larval brains. Arrows indicate full-length atrophin protein forms
at 280 kDa. Arrowhead indicates a shorter form of atrophin protein (150 kDa) that appears on Gal4-driven overexpression of the endogenous
atrophin gene and in themiR-8mutants. Note: the band does not comigrate with the 150 kDa band seen in the control sample (control:w1118 flies).
EP: animals overexpressing atrophin under Gal4 control from an EP-element insertion at the endogenous atrophin gene. The origin of the various
protein forms is unclear, particularly the shorter 150 kDa form, as alternative RNA products that might account for these protein forms have not
been reported.
(B) Histogram showing the effect of reducing atrophin activity in the miR-8 mutant background. Removing one copy of atrophin in the miR-8D2/D3
mutant rescued the survival defect by 50% (t test: 9.1 3 107) and the leg defect by 40% (t test: 1.8 3 104). The data represent an average ±
SD for 13 batches of 100 flies for each genotype.
(C) Overexpressing atrophin under the control of miR-8Gal4 results in phenotypes that strongly resemble the miR-8 mutant ones. Survival and leg
defects were similar to the ones ofmiR-8, and the wing phenotype was less penetrant. The data represent an average ± SD for 7 batches of 100 flies
for each genotype.showed leg and wing malformations resembling those in
the miR-8 mutants (Figure 5C).
Elevated Atrophin Levels Increase CNS Apoptosis
and Cause Behavioral Defects inmiR-8 Mutants
The finding that misregulation of atrophin is responsible
for at least part of the miR-8 mutant phenotype is intrigu-
ing in light of the association of its mammalian orthologs,
atrophin-1 and REREwith neurodegenerative disease and
apoptosis (Kanazawa, 1999; Ross et al., 1999; Waerner
et al., 2001). Bilen et al., (2006) have provided evidence
that miRNAs, including the antiapoptotic miRNA bantam
(Brennecke et al., 2003), limit the severity of polyglutamine
repeat-induced neurodegeneration. In this context we
asked whether the elevated expression of atrophin in-
duced in miR-8 mutants might be mediated through ad-
verse effects on the nervous system. We observed an
elevated level of apoptosis in the third instar larval brains
of miR-8 mutants, detected by antibody to the activated
form of caspase 3 (Figure 6A). Expressing the endogenous
atrophin gene in miR-8-expressing cells under miR-8 Gal4
control produced a comparable defect (Figure 6A), sug-
gesting that elevated atrophin levels are largely responsi-
ble for themiR-8mutant defect. Although modest in mag-
nitude at the third instar stage, in both cases these
differences were statistically significant (p < 0.05). Com-
parison of miR-8 expression with caspase activation
showed that a considerable fraction of the apoptotic cells
in the brain were expressing miR-8 (compare Figures 6A
and 6B). Increased expression of atrophin in these cells
caused increased apoptosis.140 Cell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc.The finding of elevated apoptosis in the brain raised the
possibility of impaired central nervous system function.
Impaired motor coordination could explain the eclosion
defects observed in miR-8 mutants. We next asked
whether reducing apoptosis in themiR-8mutant could re-
duce the severity of the eclosion defect. In the course of
these experiments, it became evident that low-level
Gal4-independent expression of the transgene encoding
the cell-death inhibitor p35 was sufficient to increase the
number of miR-8 mutant animals that eclosed success-
fully (Figure 6C). This difference was statistically signifi-
cant (p < 0.05).
To further explore the possibility of impaired motor co-
ordination in miR-8 mutants, we made use of a simple
behavioral assay. Flies are negatively geotactic, and nor-
mal animals climbed rapidly to the top of a tube (Fig-
ure 6D). For comparison withmiR-8mutants, we selected
only mutant flies that were morphologically normal and
that had survived the early phase of posteclosion lethality.
Such flies showed no reduction in lifespan compared to
control flies, suggesting that they are not generally un-
healthy (not shown). As such, they reflect the least im-
paired range of the mutant phenotypic spectrum. Yet, at
3 days of age, the miR-8 mutants performed less well in
the climbing assay. This difference was statistically signif-
icant (p < 0.05). A few mutant flies climbed as well as the
controls, but most were slow, and many were unable to
complete the task in the allotted time. The range of individ-
ual performance is reflected by the larger standard devia-
tion for the miR-8 mutants.
To ask whether the impaired performance in the
climbing assay was due to elevated atrophin levels, we
Figure 6. CNS Apoptosis and Behavioral Defects in miR-8 Mutants
(A)Histogramshowing thenumberofapoptoticcells in thebrainsofcontrol andmiR-8mutant third instar larvae.Apoptoticcellsweredetectedbyantibody
to the activated form of caspase 3. Data represent the average (± SD). n = 32 for control, n = 27 formiR-8D2/D3, and n = 16 formiR-8Gal4/EP-atro.
(B) Histogram showing the number of apoptotic miR-8-expressing cells in the brains of third instar miR-8 Gal4 UAS-GFP larvae and larvae also ex-
pressing atrophin under miR-8 Gal4 control. miR-8-expressing cells were visualized by antibody to GFP. Apoptotic cells were detected by antibody
to the activated form of caspase 3. Data represent the average (± SD). n = 21 for control (miR-8Gal4,UAS-GFP) and n = 35 for miR-8Gal4,UAS-GFP/
EP-atro.
(C) Histogram showing survival of miR-8mutants without and with a UAS-p35 transgene in the background. Leaky transcription of p35 partially rescued
the survival defect of miR-8 mutants. The miR-8 mutant data represent an average ± SD for 5 batches and the data on miR-8 mutant plus UAS-p35 an
average ± SD for 8 batches of 100 flies.
(D) Histogram showing the time needed for control, miR-8 mutant (miR-8D2/D3), miR-8-atro mutant (miR-8D2/D3;atro35) and atro-overexpressing
(miR-8Gal4/EP-atro) flies to climb to the top of a tube. The same flies were tested once 3 days and once 9 days posteclosion. Climbing ability reflects
coordination. Data represent the average (± SD) for 30 flies (15 males and 15 females) of each genotype. Only morphologically normal mutants were
used. Control flies climb rapidly to the top of a tube. Especially after 9 days, miR-8 mutants climbed poorly and had not reached the top in 120 s, the
maximum time allowed. However, some mutants performed as well as controls.compared the performance of miR-8 mutant flies with
one or two copies of the atrophin gene. The performance
of the flies with a lower level of atrophin activity was signif-
icantly improved at 3 days of age (Figure 6D; p < 0.05). At 9
days of age,miR-8mutants showed a greater impairment
than in 3 day flies (p < 0.001), and this behavioral defect
could still be ameliorated to a considerable degree by re-
duced atrophin expression (p < 0.001). By day 9, elevated
atrophin expression in an otherwise normal fly under
miR-8 Gal4 control was sufficient to cause a similar defect
(p < 0.05). This defect was not yet apparent at day 3. Al-
though the assay does not permit us to determine if the
climbing defect is solely due to impaired motor coordina-
tion, it does suggest that elevated atrophin expression in
themiR-8 mutant causes a central nervous system disor-
der with behavioral consequences. The age dependence
of this defect may reflect ongoing apoptosis in the central
nervous system (CNS) due to persistent elevated atrophin
expression. However, we do not exclude the possibility
that a requirement for miR-8 function in other tissues
might also contribute to these defects.
Atrophin Is a Tuning Target of MiR-8
Many miRNAs are thought to act by reducing expression
of their targets to inconsequential levels, often by reducing
target-RNA levels in the miRNA-expressing cells (Bartel
and Chen, 2004; Lim et al., 2005; Farh et al., 2005; Stark
et al., 2005; reviewed in Bushati and Cohen, 2007). It
has also been suggested that miRNAs might, in some
cases, buffer target levels, to prevent potentially detrimen-
tal excess expression while allowing required expression
of the target. Bartel and Chen (2004) coined the term
tuning targets to describe this relationship.This mode of action implies a need for coexpression of
themiRNA and its target. atrophinmRNA and protein have
been reported to be ubiquitously expressed throughout
development (Erkner et al., 2002; Zhang et al., 2002).
miR-8 shows pattered expression in many tissues, includ-
ing the CNS, where it overlaps with atrophin expression
(Figure S3). In view of their coexpression and the observa-
tion that excess atrophin contributes to themiR-8 pheno-
type, we wondered whether the regulatory relationship
between miR-8 and atrophin might be of this type. To
address this, we chose to selectively eliminate atrophin
in miR-8-expressing cells by driving a UAS-atroRNAi trans-
gene under control of miR-8 Gal4. Making use of the
temperature sensitivity of Gal4 to increase expression of
the RNAi construct, we found that at 29C the survival
rate of the atroRNAi-expressing animals was reduced to
about half of the level of the controls (Figure 7A). At 25C
the survival rate of the atroRNAi-expressing animals de-
creased to 70% the level of the controls but was further
reduced to 50% in atroRNAi flies lacking one copy of the
endogenous atrophin gene, which reduces the starting
level of atrophin expression (Figure 7B; p < 0.05). This
enhancement of the severity of the RNAi phenotype is
most consistent with an effect mediated by knocking
down the endogenous atrophin gene rather than an off-
target effect.
All surviving atroRNAi-expressing animals showed extra
wing veins, a phenotype previously described for clones
of cells mutant for atrophin in the wing (Erkner et al.,
2002; Zhang et al., 2002). This presumably reflects the
effects of reduced atrophin expression in the miR-8-
expressing cells in the wing imaginal disc (Figure S1F).
The finding that reducing atrophin levels below theCell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc. 141
Figure 7. Atro Levels Are Tuned to Optimal Levels by miR-8
(A and B) Histograms showing survival of control and atroRNAi-overexpressing flies. The UAS-atroRNAi transgene was expressed under control of
miR-8GAL4 to knockdown atro expression in miR-8 cells. The data represent an average ± SD for four batches of 40 flies. In (A), flies were shifted to
29C at the first instar larval stage. In (B), flies were raised at 25C to reduce the effect of UAS-atroRNAi and permit comparisonwith fliesmutant for one
copy of atro (atro35).
(C) We propose thatmiR-8 functions to fine tune atro levels in order to guarantee its optimal concentrations inmiR-8-expressing cells. Elevated atro
levels, due to lack ofmiR-8, cause severe defects in animal survival, behavioral defects and increased apoptosis in the brain. Reduced atro levels lead
to impaired survival indicating that residual levels of atro, after regulation through miR-8, have a function in miR-8 cells.threshold set by miR-8 causes defects that mirror known
atrophin loss-of-function phenotypes suggests that miR-
8-expressing cells require atrophin function (Figure 7C).
Thus, atrophin can be considered to be a tuning target
of miR-8.
DISCUSSION
Our findings suggest that misregulation of atrophin is an
important factor contributing to the defects associated
with loss ofmiR-8microRNA function. Atrophins are tran-
scriptional corepressors, associated with histone deace-
tylase activity in Drosophila and in mammalian systems
(Zhang et al., 2002; Zoltewicz et al., 2004; Wang et al.,
2006). Elevated expression of a transcriptional corepres-
sor could be responsible for the extensive transcriptional
changes observed in miR-8 mutants. Indeed, misregula-
tion of transcription is thought to be a major cause of the
neurodegeneration associated with trinucleotide repeat-
expansion diseases, such as dentatorubral-pallidoluysian
atrophy (DRPLA), which is caused by atrophin-1 (reviewed
in Riley and Orr, 2006). RERE is the more similar of the
two mammalian atrophins to Drosophila atrophin. RERE
shares regulation by the miR-8-related miRNAs, miR-
200b and miR-429, as well as the ability to recruit HDACs
and serve as a transcriptional corepressor. In this context,
it is of particular interest that HDAC inhibitors have been
found to be effective against trinucleotide repeat-expan-
sion cytotoxicity (Kariya et al., 2006).
Vertebrates have multiple miR-8-related miRNAs: there
are two inmammals and four in zebrafish. In zebrafish, two
miR-8 family members are expressed in a subset of
peripheral sensory organs, known as the lateral line (Wien-142 Cell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc.holds et al., 2005). Overexpression of miR-200a or miR-
200b results in impaired migration of the sense organ
primordia and therefore fewer sense organs along the
lateral line (Ason et al., 2006). One of the phenotypes
observed in RERE mutant zebrafish is a reduced number
of lateral-line sense organs (Asai et al., 2006). The resem-
blance between the consequences of overexpressing the
miR-8 family members miR-200a and miR-200b and the
RERE mutant phenotype is striking. It is therefore tempt-
ing to speculate that the regulatory relationship between
atrophin and miR-8 might be conserved in zebrafish.
miRNAs have been implicated in neurodegeneration
caused by a polygutamine repeat-expansion disease
model inDrosophila (Bilen et al., 2006). Loss of all miRNAs,
using mutants that remove proteins required for miRNA
biogenesis, caused increased sensitivity to polygutamine
repeat-induced neurodegeneration. Our findings suggest
that elevated expression of atrophin, resulting from loss
of miR-8, is sufficient to cause CNS apoptosis and to
impair performance in a behavioral assay. Although the
climbing assay may seem deceptively simple, to perform
it the fly must be able to determine which way is up, sense
the position of its limbs, and coordinate its movements.
Each of these depends on complex neural functions,
and the flies’ ability to perform them might be impaired
as a consequence of the elevated CNS apoptosis. It is
worth noting that reducing apoptosis suppressed the
pupal eclosion defect of the miR-8 mutants, which may
also have a motor coordination basis. It is tempting to in-
terpret the age dependence of the impaired performance
of miR-8 mutants in the climbing assay as a sign of pro-
gressive neurodegeneration resulting from to persistently
elevated atrophin levels. We note that the effects in the
mutant are likely concentrated in miR-8-expressing neu-
rons and, so, do not affect all neural functions. Indeed,
the mutant flies that survive beyond the first day after
eclosion do not show the reduced lifespan associated
with massive general neurodegeneration (e.g., Bilen
et al., 2006). The ability of mammalian miR-200b and
miR-429 to downregulate RERE raises the possibility
that they might limit HDAC activity. If so, mutations in
miR-200b and miR-429 might be worth exploring as
potential risk factors for DRPLA.
Recent computational and experimental studies have
suggested that many miRNAs show essentially reciprocal
patterns of expression to their target RNAs, with target
RNA levels being naturally low in the miRNA-expressing
cells or tissues (Lim et al., 2005; Stark et al., 2005; Farh
et al., 2005). This has led to the proposal that the main
role of many miRNAs is to reduce target-RNA expression
to inconsequential levels. Bartel & Chen (2004) also pro-
posed that some miRNA-target relationships may be
described as tuning, in which the miRNA buffers target
expression levels. A critical distinction between the switch
and tuning modes of regulation is that in switch mode the
target is reduced to an inconsequential level, whereas in
the tuning mode the remaining level of target expression
must be required in the miRNA-expressing cell (reviewed
in Bushati and Cohen, 2007). We have provided evidence
that the relationship between miR-8 and atrophin consti-
tutes an example of the latter type. Both atrophin and
miR-8 are very broadly expressed during development,
and our findings indicate that further reducing the expres-
sion of atrophin in miR-8-expressing cells causes devel-
opmental defects. Thus, the level of atrophin resulting
from miR-8-mediated regulation can be seen as being
optimal for these cells—neither too high nor too low (illus-
trated in Figure 7C).
EXPERIMENTAL PROCEDURES
Fly Strains
mir-8Gal4 (P{GawB}NP5247) was obtained from the Kyoto stock cen-
ter. P{EP}2269 and P{EP}2239 were obtained from the Szeged stock
center. The Drosophila atrophin gene is also known as grunge (Erkner
et al., 2002). EP-atro, P{EPgy2}GugEY14339, used for atrophin over-
expression, and the P(LacZ w+)gugj5A3 (atro-lacZ) line were obtained
from the Bloomington stock center, and are described in flybase
(http://flybase.bio.indiana.edu). UAS-atroRNAi flies were obtained
from Barry Dixon.
Mutant Generation
Targeted homologous recombination was performed as described
(Gong and Golic, 2003). Left and right arms of the targeting vector
were prepared by PCR of 3 kb fragments from BAC DNA using oligos
GCAgcggccgcGGCATGGGATTGGACTTGG and ATGgcatgcCTAAT
TAGCAAGATTCGGTATTC for the left flank and GTCggcgcgccAGAG
TGGATAATGCGAAGACAAG and TAAcgtacgCGGAAAGTCATAGAAA
GCGATAG for the right flank. Transgenic flies carrying the targeting
construct were crossed to flies with heat-inducible FLP recombinase
and I-SceI endonuclease (70FLP and 70I-SceI, Bloomington Stock
Center), and the resulting progeny were heat shocked for 45 min at
38C on day 3 of development. Mosaic-eyed females were crossed
to If/CyO males. Targeting events were mapped to the second chro-mosome in the next generation. Imprecise excisions were generated
by crossing P{EP}2239 and P{EP}2269 to flies expressing the D2-3
transposase (Robertson et al., 1988). Deletions in the excisions miR-
8D1 and miR-8D2 were determined by sequencing DNA fragments
spanning the breakpoints.
Northern Blots
Total RNA from adult flies was resolved on a 15% denaturing acrylam-
ide gel. Fifteen micrograms of RNA were loaded per lane. As a control
w1118 flies were used. The blot was probed with a 23 nt 50 end-labeled
oligonucleotide complementary to the mature form of miR-8 (GAC
ATCTTTACCTGACAGTATTA), end-labeled with T4 polynucleotide
kinase (New England Biolabs). A tRNA probe was used as a loading
control (Lagos-Quintana et al., 2001).
miRNA-30UTR Alignment
microRNA-30UTR alignment was performed using the BiBiServ server
(Rehmsmeier et al., 2004; http://bibiserv.techfak.uni-bielefeld.de/
rnahybrid/submission.html).
Microarray
Probe preparation and hybridization were as described in Sandmann
et al., (2006). The microarrays contained clones from the Drosophila
DGC1 andDGC2 collections. To identify genes differentially expressed
miR-8 mutant pupae were compared with stage-matched controls. A
one-class Significance Analysis of Microarrays (Tusher et al., 2001)
was performed on two different mutant combinations, miR-8D2/D1 or
miR-8D2/D3, compared to w1118 controls. Genes with significance
score of q < 0.05 and a fold enrichment of log2 > 0.7 or < 0.7 were
considered to be differentially regulated.
Quantitative RT-PCR
PCRs were performed using the ABI7500 machine and the ABI SYBR
green system. Measurements were normalized to mitochondrial large
ribosomal RNA (mtlrRNA1, 50-AAAAAGATTGCGACCTCGAT and 50-
AAACCAACCTGGCTTACACC). Nuclear, intron-containing RNA is
not subject to miRNA posttranscriptional regulation. We therefore per-
formed Q-PCR on an intron versus an exon to assay transcription
levels of the atrophin locus, as distinct from mRNA levels. Primers to
assay intron containing RNA are 50-GCCTTGCTTATCTTCGAAACC
and 50-TCCAGCCTTTTAATGCGTCT. Primers to assay mRNA levels
are 50-CCATCCGACGGAGCCATTGCCC and 50-CATTCGGTGTCGTC
CGGTTTTG. Firefly luciferase primers are 50-CCGCCGTTGTTGTTTTG
and 50-CTCCGCGCAACTTTTTC Renilla luciferase primers are 50-
CGGACCCAGGATTCTTTT and 50-TTGCGAAAAATGAAGACCT.
UTR Reporter Assays
Luciferase 30UTR reporter andmiRNA plasmids were expressed under
control of the tubulin promoter. miR-8 was expressed from a plasmid
containing a 400 bp genomic region, including the hairpin. S2 cells
were transfected in 24-well plates with 0.025 mg of the firefly luciferase
reporter plasmid, 0.025 mg of a Renilla luciferase expressing plasmid
(transfection control), and 0.25 mg of the miRNA expression plasmid
or empty vector. Transfections were performed in triplicate. Dual-lucif-
erase assays (Promega) were performed 2.5 days after transfection
according to the manufacturer’s protocol.
Immunoblotting
Protein lysates were prepared from late third instar larval brains by
crushing them in SDS sample-loading buffer and boiling the samples
for 5 min. Samples were loaded onto 6% SDS-PAGE gels and trans-
ferred to a nitrocellulose membrane via wet transfer overnight at 150
mA. The nitrocellulose membrane was incubated with specific anti-
bodies diluted in 5% fat-free milk. The rabbit anti-atrophin (D3) (Erkner
et al., 2002) was used at a 1:1000 dilution. The protein bands were
visualized using anti-rabbit secondary antibody conjugated with HRP
(used 1:5000) followed by ECL Chemiluminiscence reagent accordingCell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc. 143
to the manufacturer’s instructions (Perkin-Elmer). Membranes were
stripped and reprobed with rabbit anti-Kinesin (Cytoskeleton) used
at a 1:10,000 dilution.
miRNA In Situs
Pri-miRNA transcript in situ hybridization was as described (Kosman
et al., 2004) except for the following: embryos were not treated with
Xylene, anti-pri-miRNA probes were labeled with DIG-11 UTP but
not hydrolyzed, and probes were detected with primary anti-DIG
POD antibody (1:200; Roche #1207733). miRNA was detected first
with the tyramide signal-amplification method (Molecular Probes
#T-20939; 2 hr at room temperature). To obtain a better signal, a
second amplification round was performed using HRP coupled anti-
oregon green antibody (1:400; Molecular Probes #A21253).
Immunocytochemistry
Embryos and imaginal discs were fixed in 4% formaldehyde and
stained with standard methods. Embryos were stained with mouse
anti-engrailed (used 1:10), rabbit anti-dMef-2 (1:250), and mouse
and rabbit anti-GFP (used 1:200). Imaginal discs were stained with
mouse anti-GFP. For detecting apoptotic cells, late third instar larval
brains were stained with rabbit anti-cleaved caspase 3 (Asp175) (Cell
Signaling Technology, used 1:200). Primary antibodies were incubated
overnight at 4C and secondary antibody for 3 hr at room temperature.
Quantitative Measurement of the Occurrence of Apoptosis
To count the number of apoptosis-positive spots in the images, we
developed the following image analysis protocol using ImageJ version
1.38a (WS Rasband, NIH, Bethesda, Maryland, USA; http://rsb.info.
nih.gov/ij/). Three-dimensional 8-bit image data were converted to
two-dimensional images by maximum intensity projection along the
Z axis onto the XY plane. A duplicate of this projection image was
created, and a Gaussian filter with 20 px diameter was applied to
blur the duplicate to prepare the background image. The original pro-
jection image was subtracted from the blurred duplicate to obtain
a background-subtracted image. This subtracted imagewas threshold
filtered (minimum threshold level at 12 and maximum at 255). The bi-
nary image still contains noise from the acquisition. To remove this
noise, the open operation was applied. Finally, we measured the
number of particles within the processed image automatically while
leaving out particles larger than 12 px that are expected to be due to
nonspecific labeling. The ImageJ macro used for this automatic
measurement is available on request.
Colocalization ofmiR-8 Positive and Apoptotic Cells
miR-8 Gal4, UAS-GFP allowed us to count apoptosis via anti-caspase
3 staining inmiR-8-expressing cells. To measure the degree of coloc-
alization of miR-8 expression and apoptosis, we threshold filtered
stacks from each channel and binarized the images. To segment the
signal successfully, various threshold values were tested manually,
and sufficient threshold values were determined for each channel prior
to image processing. We then counted the number of apoptosis chan-
nel pixels overlapping with the GFP channel signal. The measurement
was done for each Z slice, and then the valueswere summed for the 3D
data set from each brain. A macro was written for the semiautomation
of these measurements using an image processing/analysis software
ImageJ (Rasband, W.S., U. S. National Institutes of Health, Bethesda,
Maryland, USA; http://rsb.info.nih.gov/ij/).
Climbing Assay
Single flies were placed in an empty vial, marked with a line 5 cm from
the bottom. Flies were allowed to rest for 15 min before being tapped
down to the bottom of the vial. The time required to climb and cross the
5 cm line was recorded with a cutoff at 120 s. Thirty flies (fifteen males
and fifteen females) of each genotype were scored. Flies were raised in
comparable uncrowded conditions at 25C. The same flies were
tested once at 3 days and again at 9 days posteclosion.144 Cell 131, 136–145, October 5, 2007 ª2007 Elsevier Inc.Supplemental Data
Supplemental Data include three figures, one table, and a movie and
can be found with this article online at http://www.cell.com/cgi/
content/full/131/1/136/DC1/.
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